{"product_id":"global-radiodermatitis-market-size-trends-growth-opportunity-by-product-oral-and-dressings-by-distribution-channel-hospital-pharmacy-retail-pharmacy-by-region-and-forecast-till-2027","title":"Global Radiodermatitis Market Size, Trends \u0026 Growth Opportunity By Product (Oral, and Dressings), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region and Forecast till 2027","description":"\u003cp\u003eGlobal Radiodermatitis Market Size, Trends, \u0026amp; Growth Opportunity by Product (Oral, Dressings), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, and Forecast till 2027.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Radiodermatitis Market\u003c\/p\u003e \n\n\u003cp\u003eThe global radiodermatitis market was valued at USD 4362.5 million in 2021 which is expected to reach USD 674.22 million by 2027, at a CAGR 9.09 % from 2022-2027.\u003c\/p\u003e\n\n\u003cp\u003eRadiation dermatitis, X-ray dermatitis, and radiation injury are all names for radiodermatitis. It is an unintended consequence of external beam ionising radiation. Radiotherapy is used to treat cancer or other disorders, which is the most common cause of radiothermatitis.\u003c\/p\u003e \n\n\u003cp\u003eMarket Drivers\u003c\/p\u003e\n\n\u003cp\u003eThe rise in cancer prevalence is the primary driving factor projected to increase the worldwide radiodermatitis market's growth. For example, the American Cancer Society estimates that in 2019, around 1,762,450 cancer cases will be identified and approximately 606,880 cancer deaths will occur in the United States. Furthermore, increased research \u0026amp; development of new medicines for radiodermatitis therapy will positively benefit global radiodermatitis market growth. Furthermore, investments in raising awareness about radiation-induced skin damage are likely to fuel the worldwide radiodermatitis market's expansion.\u003c\/p\u003e\n\n\u003cp\u003eMarket Restraints\u003c\/p\u003e\n\n\u003cp\u003eHowever, the high cost of dressings such as honey-impregnated dressing and silicone dressing is projected to limit the worldwide radiodermatitis market's growth.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation\u003c\/p\u003e\n\n\u003cp\u003eGlobal Radiodermatitis Market is segmented into products such as topical (corticosteroids, hydrophilic creams, antibiotics, and others), Oral, and Dressings (No Sting barrier film, Silicone Coated dressings, Honey impregnated gauze, and Others). Further, Global Radiodermatitis Market is segmented into distribution channel such as Hospital Pharmacy, Retail Pharmacy, and Others.\u003c\/p\u003e\n\n\u003cp\u003eRegional analysis\u003c\/p\u003e \n\n\u003cp\u003eAlso, Global Radiodermatitis Market is segmented into five regions, such as North America, Latin America, Europe, Asia Pacific, and the Middle East \u0026amp; Africa.\u003c\/p\u003e\n\n\u003cp\u003eMarket Key Players\u003c\/p\u003e\n\n\u003cp\u003eVarious key players are discussed in this report, such as Jay Pharma, Smith \u0026amp; Nephew Plc, Stratpharma AG, Kannalife, Inc., Molnlycke Health Care, Intermed Pharmaceuticals, DermaSciences, Inc., ConvaTec Group PLC, BMG Pharma S.r.l., and Acelity, Inc. (3M).\u003c\/p\u003e\n\n\u003cp\u003eMarket Taxonomy\u003c\/p\u003e\n\n\u003cp\u003eBy Product TopicalCorticosteroidsHydrophilic CreamsAntibioticsOthers Oral DressingsNo Sting barrier film Silicone Coated dressings Honey impregnated gauze OthersBy Distribution Channel Hospital Pharmacy Retail Pharmacy OthersBy Region North America Latin America Europe Asia Pacific Middle East \u0026amp; Africa\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ 141 Pages \/ MCW16235444","offer_id":47651207315762,"sku":null,"price":4740.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-radiodermatitis-market-size-trends-growth-opportunity-by-product-oral-and-dressings-by-distribution-channel-hospital-pharmacy-retail-pharmacy-by-region-and-forecast-till-2027","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}